Literature DB >> 1903717

Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue.

K Takayama1, I Kudo, D K Kim, K Nagata, Y Nozawa, K Inoue.   

Abstract

A phospholipase A2 with an arachidonoyl residue preference was purified about 11,700-fold from human platelet soluble fraction to near homogeneity. The purified phospholipase A2 exhibited a molecular mass of about 90 kDa on SDS polyacrylamide gel electrophoresis and hydrolyzed phospholipids with an arachidonoyl residue more effectively than those with a linoleoyl residue. The catalytic activity of the purified enzyme detected with phosphatidylcholine as a substrate increased sharply between 3 x 10(-7) and 10(-6) M free calcium ion. Thus, the 90-kDa phospholipase A2 is considered to be a novel enzyme, distinct from the 14-kDa one previously purified from human platelets. The 90-kDa phospholipase A2 may participate mainly in arachidonate metabolism of platelets.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903717     DOI: 10.1016/0014-5793(91)80506-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  The properties of a cloned human high-molecular-mass cytosolic phospholipase A2 investigated using a continuous fluorescence displacement assay: evidence for enzyme clustering on phospholipid vesicles.

Authors:  A Creaney; D J Masters; M B Needham; R D Gordon; R Mott; D C Wilton
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

2.  sn-position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry.

Authors:  Christopher Beermann; Michael Möbius; Nadine Winterling; Joachim J Schmitt; Günther Boehm
Journal:  Lipids       Date:  2005-02       Impact factor: 1.880

3.  Role of cytosolic phospholipase A2 in cytokine-stimulated prostaglandin release by human gallbladder cells.

Authors:  E M Grossmann; W E Longo; J E Mazuski; N Panesar; D L Kaminski
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

4.  Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.

Authors:  A N Fonteh; J M Samet; F H Chilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.

Authors:  I Lilja; K Smedh; G Olaison; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

6.  Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.

Authors:  R Cholbi; M L Ferrándiz; M C Terencio; S De Rosa; M J Alcaraz; M Payá
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

7.  Cytosolic phospholipase A2 from human monocytic cells: characterization of substrate specificity and Ca(2+)-dependent membrane association.

Authors:  W Rehfeldt; K Resch; M Goppelt-Struebe
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

8.  Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.

Authors:  J Pfeilschifter; C Schalkwijk; V A Briner; H van den Bosch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.

Authors:  A Miyake; H Yamamoto; E Kubota; K Hamaguchi; A Kouda; K Honda; H Kawashima
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

10.  Arachidonic acid metabolites and glucocorticoid regulatory mechanism in cultured porcine tracheal smooth muscle cells.

Authors:  H Tanaka; K Watanabe; N Tamaru; M Yoshida
Journal:  Lung       Date:  1995       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.